2020 witnessed outperformance from
as investors expected these firms to be better placed to navigate the COVID-19 environment. Exhibit 1 shows that this outperformance led to the largest names accounting for an unusually high proportion of the U.S. large-cap equity benchmark, and therefore having a bigger impact on the index’s returns.
Launched in January 2003, the
weights each S&P 500 company equally at each quarterly rebalance. Exhibit 2 shows the historical benefit from applying this weighting scheme within U.S. large caps;
Rather than being strictly a U.S. phenomenon,
,
.
for example,
. This exposure occurs because, as Exhibit 3 illustrates, the distribution of weights within equal weight indices is far more even than within their market-cap weighted parents. For example, the S&P 500 Equal Weight Index is far less sensitive to the performance of the largest names in the market and offers more exposure to smaller S&P 500 companies.
All else equal, if the largest companies (to which equal weight has less sensitivity) outperform, concentration rises, and equal weight is likely to underperform its cap-weighted benchmark. Conversely, outperformance among smaller companies (to which equal weight has greater allocations) leads to reduced concentration and the likelihood of equal weight outperformance. Exhibit 4 shows that this dynamic is
what has been observed historically. The S&P 500 Equal Weight Index’s cumulative relative total return versus the S&P 500 typically rose (fell) as concentration, measured by the cumulative weight of the largest five S&P 500 companies, fell (rose). This dynamic includes December 2020,
.
The current market environment may present an opportunity for investors to consider Equal Weight in order to diversify away from some of the largest market constituents. The S&P 500 Equal Weight Index’s smaller size bias may also benefit investors anticipating reductions in market concentration.